MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy.
MIM SurePlan MRT has received CE Mark approval for new artificial intelligence (AI) segmentation models, which simplify the contouring process for dosimetry. AI segmentation provides significant time savings and enhanced results compared to manual and atlas-based segmentation.
In addition to these new AI segmentation models, MIM SurePlan MRT now includes two single timepoint methods – the Hänscheid approach and the prior-information approach.
